Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01630993 · ClinicalTrials.gov registry record · Early Phase 1
Milking the Umbilical Cord at Term Cesarean Birth
A Early Phase 1 study of Anemia, sponsored by University of Rhode Island.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 24
- Enrollment target
- 1
- Study location
NCT01630993: Completed Early Phase 1 study of Anemia, sponsored by University of Rhode Island.
NCT01630993 is a Early Phase 1 study of Anemia that has completed, run by University of Rhode Island. The registered enrollment target is 24 participants, below the 427-participant average among 72 other Anemia trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01630993, a Early Phase 1 study of Anemia, has completed, sponsored by University of Rhode Island.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 24 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this pilot study is to determine if umbilical cord milking at the time of scheduled cesarean section effects the hemoglobin and hematocrit levels of full-term infants as determined by hemoglobin and hematocrit levels at 36-48 hours of life. This study will help to establish the feasibility of umbilical cord milking as an alternative to delayed clamping at the time of planned cesarean section.
Primary Outcome
At 36-48 hours, term infants (born by planned cesarean section) exposed to umbilical cord milking will have higher hemoglobin and hematocrit levels compared to infants exposed to immediate cord clamping
Conditions Studied
Interventions
- OTHER Umbilical Cord Milking
Study Locations (1)
Rhode Island
- Women & Infants Hospital - Providence
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2008-05 |
| Est. Completion | 2009-12 |
| Phase | Early Phase 1 |
What the finished NCT01630993 record still lists
NCT01630993 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 24 participants, a relatively small participant target, below the 427-participant average among 72 other Anemia trials with a reported enrollment target (94% lower).
The record links to 1 condition, with Anemia appearing as the primary indexed condition, and to 1 intervention - of which Umbilical Cord Milking is the first listed.
NCT01630993 reports a single indexed study location in Rhode Island.
Frequently Asked Questions
What is clinical trial NCT01630993 about?
NCT01630993 is a clinical study titled "Milking the Umbilical Cord at Term Cesarean Birth". The purpose of this pilot study is to determine if umbilical cord milking at the time of scheduled cesarean section effects the hemoglobin and hematocrit levels of full-term infants as determined by hemoglobin and hematocrit levels at 36-48 hours of life. This study will help to establish the feasib...
What is the current status of trial NCT01630993?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 24 participants. The study started on 2008-05. Estimated completion is 2009-12.
What conditions does trial NCT01630993 study?
This clinical trial studies the following conditions: Anemia.
What interventions are being tested in trial NCT01630993?
The interventions under investigation include: Umbilical Cord Milking (OTHER).
Who is sponsoring clinical trial NCT01630993?
This trial is sponsored by University of Rhode Island, which has 29 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01630993 being conducted?
This trial has 1 study location across Rhode Island. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Anemia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01630993's enrollment target sits among peer trials
24 67th of 72 higher than 6 of 72 other Anemia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Anemia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Luspatercept for Anemia in Lower Risk MDS or Non-proliferative MDS/MPN Neoplasms
RECRUITING · Phase 2
-
Study of DISC-0974-201 in Participants With IBD and Anemia
RECRUITING · Phase 2
-
Study of DISC-0974 (RALLY-MF) in Participants With Myelofibrosis or Myelodysplastic Syndrome and Anemia
RECRUITING · Phase 1
-
129Xe MRI Cardiopulmonary
RECRUITING · Phase 2
-
A Study to Compare Elritercept With Epoetin Alfa to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood Transfusions
RECRUITING · Phase 3
-
177Lu-PSMA-617 in Metastatic Castration Resistant Prostate Cancer (mCRPC) With Bone Marrow Involvement and Cytopenia
RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02331979 · 24 participants · NA
Improving Bladder Function in SCI by Neuromodulation
- NCT03096197 · 24 participants · NA
Exoskeleton and Spinal Cord Stimulation for SCI
- NCT03223922 · 24 participants · NA
Neurocognitive Functioning With Genu-Sparing Whole Brain Radiation Therapy for Brain Metastases
- NCT03326921 · 24 participants · Phase 1
HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia